Jason R. Kelly, See remarks at Ginkgo Bioworks Holdings, Inc. (DNA), sold 200,000 shares at $1.32 ($263K) on 2023-12-06, disclosed to the SEC on 2023-12-08.
Scheduled sale ($263k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.32 | 100,000 | $132K | 50.2% |
| 2 | $1.31 | 100,000 | $131K | 49.8% |
| Total | $1.31 avg | 200,000 | $263K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $353K | — | Filing → |
| DNA | SELL | 2023-12-15 | $595K | — | Filing → |
| DNA | SELL | 2023-12-01 | $280K | — | Filing → |